microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

[1]  D. Fan,et al.  Regulation of UHRF1 by miR‐146a/b modulates gastric cancer invasion and metastasis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Wong,et al.  UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9 , 2013, Nature Communications.

[3]  Z. Ren,et al.  HAb18G/CD147 promotes epithelial–mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug , 2011, Oncogene.

[4]  R. Lidereau,et al.  Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers , 2011, EMBO molecular medicine.

[5]  Yuhai Zhao,et al.  Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[6]  I. Georgiou,et al.  A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. , 2010, Joint, bone, spine : revue du rhumatisme.

[7]  X. Zhang,et al.  Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism. , 2010, Hepato-gastroenterology.

[8]  H. El‐Serag,et al.  The changing pattern of epidemiology in hepatocellular carcinoma. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  E. S. Harris,et al.  Adenomatous Polyposis Coli Regulates Endothelial Cell Migration Independent of Roles in β-Catenin Signaling and Cell–Cell Adhesion , 2010, Molecular biology of the cell.

[10]  I. Georgiou,et al.  The Role of microRNA‐146a (miR‐146a) and its Target IL‐1R‐Associated Kinase (IRAK1) in Psoriatic Arthritis Susceptibility , 2010, Scandinavian journal of immunology.

[11]  I. Ng,et al.  RhoGTPases and Rho‐effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[12]  Zhiwei Wang,et al.  miR-146a suppresses invasion of pancreatic cancer cells. , 2010, Cancer research.

[13]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[14]  Fan Wu,et al.  Novel role for epidermal growth factor‐like domain 7 in metastasis of human hepatocellular carcinoma , 2009, Hepatology.

[15]  Yin-kun Liu,et al.  Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells , 2009, BMC Cancer.

[16]  Jing Xu,et al.  HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection , 2009, Histopathology.

[17]  Yi Tie,et al.  MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma , 2009, Hepatology.

[18]  Jin-Lin Hou,et al.  Hepatocellular carcinoma in the Asia pacific region , 2009, Journal of gastroenterology and hepatology.

[19]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[20]  R. Gish,et al.  Medical therapies to extend survival in hepatocellular carcinoma. , 2008, Clinical advances in hematology & oncology : H&O.

[21]  S. Wongkham,et al.  Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.

[22]  H. Varnholt,et al.  The role of microRNAs in primary liver cancer. , 2008, Annals of hepatology.

[23]  Donald C. Chang,et al.  Loss of mir-146a function in hormone-refractory prostate cancer. , 2008, RNA.

[24]  Ping Zhu,et al.  HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma , 2007, Molecular Cancer Research.

[25]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[26]  Takafumi Yoshida,et al.  Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors , 2006, Oncogene.

[27]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[28]  K. Livak,et al.  Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.

[29]  Robert N. Taylor,et al.  beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. , 2003, Cancer research.

[30]  T. Nagaya,et al.  Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells , 2002, Breast Cancer Research and Treatment.

[31]  Mariann Bienz,et al.  The subcellular destinations of apc proteins , 2002, Nature Reviews Molecular Cell Biology.

[32]  H. Clevers,et al.  Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor , 1999, Current Biology.

[33]  R. Burgemeister.  Nucleic acids extraction from laser microdissected FFPE tissue sections. , 2011, Methods in molecular biology.

[34]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[35]  T. Nagaya,et al.  Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. , 2002, Breast cancer research and treatment.